Advertisement

BRIEF-Pharma Mar Licenses Marine-Derived Payloads To Seattle Genetics

From Reuters - February 13, 2018

Feb 14 (Reuters) - PHARMA MAR SA:

* LICENSES FULLY SYNTHETIC MARINE-DERIVED PAYLOADS TO SEATTLE GENETICS FOR USE IN DRUG CONJUGATES

* SAYS WILL RECEIVE UPFRONT PAYMENT OF $5.0 MILLION ON SIGNING, FOLLOWED BY DEVELOPMENT MILESTONES IF A PRODUCT ENTERS CLINICAL DEVELOPMENT CONDUCTED BY SEATTLE GENETICS

Advertisement

Continue reading at Reuters »